AnaptysBio, Inc. (ANAB) NASDAQ
51.63
+0.27(+0.53%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
51.63
+0.27(+0.53%)
Currency In USD
| Market Cap | 898.14M |
| Enterprise Value | 674.06M |
| P/E Ratio | -55.3 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 9.58 |
| Price/Book Ratio | 116.21 |
| Enterprise/Revenue | 9.7 |
| Enterprise/EBITDA | 42.29 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.12 |
| Operating Margin | 0.18 |
| Return On Assets | -0.08 |
| Return On Equity | 4.43 |
| Revenue | 234.6M |
| Revenue/Share | 8.1 |
| Gross Profit | 232.18M |
| EBITDA | 50.32M |
| Net Income | -13.23M |
| Diluted EPS | -0.46 |
| Total Cash | 286.46M |
| Total Cash/Share | 9.98 |
| Total Debt | 277.36M |
| Total Debt/Equity | 21.76 |
| Current Ratio | 7.58 |
| Book Value Per Share | 0.44 |
| 52-Week Change | 233.96 |
| 52-Week High | 72.36 |
| 52-Week Low | 11.4 |
| Moving Average 50 Days | 54.58 |
| Moving Average 200 Days | 34.36 |
| Average Volume | 803,117 |
| Shares Outstanding | 43.12M |
| % Held by Institutions | 152.41 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:2 |
| Last Split Date | April 20, 2026 |